Spots Global Cancer Trial Database for Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer
Official Title: An Open-Label, Multicentre, Randomised, Phase III Comparator Study of Active Symptom Control Alone or in Combination With Oral Topotecan in Patients With Relapsed Resistant SCLC
Study ID: NCT00276276
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to find out if giving oral HYCAMTIN to patients with relapsed small cell lung cancer benefits them. The study will compare how long patients live when they are given therapy to make them feel better (active symptom control) to the length of time patients live when they are also receiving oral HYCAMTIN.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Pleven, , Bulgaria
GSK Investigational Site, Plovdiv, , Bulgaria
GSK Investigational Site, Varna, , Bulgaria
GSK Investigational Site, Budapest, , Hungary
GSK Investigational Site, Budapest, , Hungary
GSK Investigational Site, Budapest, , Hungary
GSK Investigational Site, Csorna, , Hungary
GSK Investigational Site, Hungary, , Hungary
GSK Investigational Site, Miskolc, , Hungary
GSK Investigational Site, Törökbálint, , Hungary
GSK Investigational Site, Breda, , Netherlands
GSK Investigational Site, Moscow, , Russian Federation
GSK Investigational Site, Donetsk, , Ukraine
GSK Investigational Site, Lvov, , Ukraine
GSK Investigational Site, Chelmsford, Essex, United Kingdom
GSK Investigational Site, Glasgow, Lanarkshire, United Kingdom
GSK Investigational Site, Sutton, Surrey, United Kingdom
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
